M. Chalker

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants

W. Fahy, Nadia Garman, R. Marshall, 2018, European Journal of Clinical Pharmacology.

The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.

N. Austin, F. Hollis, G. Boyle, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports

A. Kirkham, N. Brickel, G. Davies, 2017, Therapeutics and clinical risk management.

Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study

H. Zetterberg, N. Andreasen, C. V. von Arnim, 2014, Alzheimer's Research & Therapy.